Hard to Treat Diseases (HTDS)

[Underworlds]

LowTrades.com To Charge Illiquidity Fees On Sell Side Of Stocks

In a telephone conversation with LowTrades today, July 10, 2009, it was revealed that LowTrades.com will now be charging their clients excessive "illiquidity fees" on the sell side when they sell any of the following stocks: Genta, Inc. (GNTA), Seamless Sales, Inc. (SMWF), and Hard To Treat Diseases (HTDS).

At the time of purchasing stocks through LowTrades.com, clients are not informed of any "illiquidity fees" that they will be assessed, neither on the buy side or the sell side of the trade. In one instance, as mentioned in my previous article, LowTrades charged a phenomenal fee of $495.30 to a client (me) several days after the purchase of 993,000 shares of Hard To Treat Diseases (HTDS).

This failure to disclose fees to investors is certain to cripple the stock trading abilities of LowTrades.com clients. It may likewise make it more difficult for certain stocks to trade on the markets.

When asked to speak with a Compliance Officer, the LowTrades.com representative refused - not once, but multiple times. According to him, clients can only communicate with compliance officers via email by writing to [e-mail]. This is a general-purpose email address at which all customer communications are delivered, thereby giving all persons within LowTrades the ability to read communications that are supposed to be designated for Compliance Officer's eyes only.

Click the link to listen to the telephone conversation with LowTrades.com.

http://www.underworlds.org/af/VN520105.WMA